Recent evidence indicates dehydrogenase reductase 9 (DHRS9) can oxidize and alter the biological activity of a diverse group of oxylipin substrates, underscoring the importance of DHRS9 in the regulation of a variety of biological processes such as inflammation, cell proliferation, and tissue repair. Importantly, mutations in DHRS9 gene resulting in amino acid substitutions S202L and D286H have been linked to an early onset case of epilepsy; whether these mutations affect the function of DHRS9 has not been investigated. The results of this study demonstrate that both mutations cause significant loss of DHRS9 functionality. However, in the case of S202L variant, the loss of catalytic activity likely stems from the impaired protein folding and/or protein stability. On the other hand, D286H DHRS9 mutant protein is relatively more stable than S202L variant, but its Km value for NAD+ (2.85 mM) is nearly 12-fold higher than that of the wild type enzyme. The three-dimensional structure of DHRS9 solved in this study provides insights into the functions of S202 and D286 residues. In addition, it reveals a strikingly large substrate binding cavity, consistent with the fact that the enzyme can process oxygenated hydrocarbons with abundant rotational freedom and of differing lengths (18-22 C). Considering that expression levels of DHRS9 in human tissues are highly sensitive to inflammatory conditions, and the existence of naturally occurring mutations in DHRS9, the structural and functional characterization of DHRS9 reported in this study is critical for a better understanding of the role of DHRS9 in inflammatory processes.
Wirth et al. (Mon,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: